CD44 and cancer: CD44-cancer cells (C4, C5), CSCs (C7, C9, and C12) and other CD44+ cancer cells (C0, C1, C2, C3, C6, C8, C10, and C11) presented different signaling communication patterns in TME, demonstrating intra-tumor heterogeneity.